Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study

Abstract

Among patients with GCA, relapses are common, often occurring during treatment. ESR and CRP are frequently normal at times of clinical relapse, highlighting the need for better biomarkers to assess disease activity in GCA. There remains a need for effective therapeutic alternatives to glucocorticoids in GCA.